{"product_id":"clinical-trial-supplies-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eClinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global clinical trial supplies market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.\u003c\/p\u003e \n\n\u003cp\u003eClinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research. Infusion pumps, nebulizers and syringe needles are the most commonly used clinical trial supplies. They are primarily used for conducting medical trials for detecting, preventing and treating various ailments, analyzing the efficiency of a treatment method, and in the diagnosis of various infectious and metabolic disorders. They also find extensive applications during respiratory, oncological, cardiovascular and neurological procedures.\u003c\/p\u003e\n\n\u003cp\u003eSignificant growth in the biopharmaceutical industry is one of the key factors driving the growth of the market. Clinical trials are gaining immense traction for treating diseases, such as HIV and cancer, along with the development of innovative drug delivery systems. Furthermore, technological advancements facilitating the development of cold chain logistics and monitoring technologies, are also acting as crucial growth-inducing factors. Product manufacturers are focusing on optimizing the production and packaging processes that can minimize wastage and enhance the overall cost-efficiency. Moreover, the emerging trend of contract research organizations (CROs) is also impacting the market growth positively. CROs enable the pharmaceutical, biotechnological and medical instrument manufacturers to outsource research activities on a contractual basis, thereby increasing the utilization of various trial supplies. Other factors, including extensive research and development (R\u0026amp;D) undertaken by both the governmental and non-governmental organizations (NGOs) for the development of advanced drugs and treatment methods, are expected to create a positive outlook for the market.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial supplies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on services, phase, therapeutic area, and end-use industry.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Services:\u003c\/p\u003e\n\n\u003cp\u003eProduct Manufacturing\u003cbr\u003e\nPackaging, Labeling and Storage\u003cbr\u003e\nLogistics and Distribution\u003cbr\u003e\n \u003cbr\u003e\nBased on the services, the market has been segmented into product manufacturing; packaging, labeling and storage; and logistics and distribution.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Phase:\u003c\/p\u003e\n\n\u003cp\u003ePhase I\u003cbr\u003e\nPhase II\u003cbr\u003e\nPhase III\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nOn the basis of the phase, the market has been segregated into phase I, phase II, phase III and others. At present, phase III exhibits a clear dominance in the market.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Therapeutic Area:\u003c\/p\u003e\n\n\u003cp\u003eOncology\u003cbr\u003e\nCardiovascular Diseases\u003cbr\u003e\nRespiratory Diseases\u003cbr\u003e\nCNS And Mental Disorders\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nThe market has been analyzed on the basis of the therapeutic area into oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, and others. Amongst these, oncology holds the largest market share.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by End-Use Industry:\u003c\/p\u003e\n\n\u003cp\u003eMedical Device Industry\u003cbr\u003e\nBiopharmaceuticals Industry\u003cbr\u003e\nPharmaceuticals Industry\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBased on the end-use industry, the market has been divided into medical devices, biopharmaceuticals, pharmaceuticals and others. Pharmaceuticals account for the majority of the total market share.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nOn the geographical front, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and Middle East and Africa. Currently, North America enjoys the leading position in the market.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, Movianto, etc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003c\/p\u003e\n\n\u003cp\u003eHow has the global clinical trial supplies market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat are the key regional markets in the industry?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global clinical trial supplies market?\u003cbr\u003e\nWhat is the breakup of the market based on the services?\u003cbr\u003e\nWhat is the breakup of the market based on the phase?\u003cbr\u003e\nWhat is the breakup of the market based on the therapeutic area?\u003cbr\u003e\nWhat is the breakup of the market based on the end-use industry?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global clinical trial supplies market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 149 Pages \/ MCW16254987","offer_id":47650446442802,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/clinical-trial-supplies-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}